In a 63-year-old man with normal sinus rhythm, occasional brief palpitations, exertional dyspnea with pleuritic chest discomfort, mild renal impairment (eGFR 55 mL/min/1.73 m², creatinine 1.33 mg/dL), and blood pressure only mildly controlled on losartan 100 mg, what are the appropriate diagnostic and therapeutic steps?

Echocardiography is the Essential Next Step

This 63-year-old man with exertional dyspnea, pleuritic chest pain, mild renal impairment (eGFR 55), and suboptimally controlled hypertension requires transthoracic echocardiography as the primary diagnostic test. 1, 2, 1

Diagnostic Rationale

The clinical presentation—exertional dyspnea with pleuritic chest pain on exertion—strongly suggests cardiac dyspnea, particularly given:

• Hypertension inadequately controlled on losartan 100 mg (maximum dose)
• Mild renal impairment (eGFR 55, creatinine 1.33), which commonly coexists with hypertensive heart disease
• Exertional symptoms without rest symptoms, suggesting either diastolic dysfunction or ischemia

Why Echocardiography First?

Echocardiography should be performed in all patients with dyspnea of suspected cardiac origin 1, 2. This modality will simultaneously evaluate:

• Left ventricular hypertrophy (LVH) from chronic hypertension—the most common cause of diastolic dysfunction in elderly hypertensive patients 3
• Diastolic dysfunction—present in up to one-third of patients with cardiac dyspnea who have normal systolic function 3
• Systolic function and ejection fraction
• Valvular abnormalities (particularly aortic stenosis, which can present with exertional dyspnea and chest pain)
• Regional wall motion abnormalities suggesting ischemia
• Pulmonary artery pressures via tricuspid regurgitation velocity

The Pleuritic Component

While pleuritic chest pain typically suggests pulmonary or pleural pathology, the negative D-dimer effectively excludes acute pulmonary embolism 4. The pleuritic quality occurring specifically with exertion (not at rest) is atypical for primary pleural disease and more consistent with cardiac limitation triggering respiratory distress.

Blood Pressure Management

Intensify Antihypertensive Therapy

The patient's blood pressure is only "mildly controlled" on losartan 100 mg (maximum dose), requiring addition of a second agent. 5

Add a calcium channel blocker (amlodipine 5-10 mg daily) or thiazide-like diuretic (chlorthalidone 12.5-25 mg daily) as the next step. Given the mild renal impairment (eGFR 55), either class is appropriate:

• Losartan dosing does NOT require adjustment at eGFR 55 6, 7, 8. Dose adjustment is only necessary when eGFR <30 mL/min/1.73 m² or in volume-depleted states 6, 8, 9
• The pharmacokinetics of losartan and its active metabolite E-3174 remain stable even with moderate renal impairment 7, 8

Critical Monitoring with Losartan and Renal Impairment

Monitor potassium and renal function within 2-3 days after adding any medication, then at 7 days, monthly for 3 months, then every 3 months 5. Key thresholds:

• Hold losartan if potassium >5.5 mEq/L or creatinine rises significantly
• Avoid potassium supplements and NSAIDs 6
• Risk of hyperkalemia increases progressively when creatinine >1.6 mg/dL 5

Statin Reinitiation

Restart statin therapy immediately. This patient has:

• Hypertension with LVH (presumed based on chronic hypertension and renal impairment)
• Cardiovascular risk factors warranting secondary prevention
• No contraindication mentioned for statin discontinuation

The AST of 13 (low-normal) suggests no hepatic concern for statin use.

Algorithmic Approach to Further Workup

If Echocardiogram Shows:

1. LVH with preserved ejection fraction and diastolic dysfunction:

• Diagnosis: Hypertensive heart disease with diastolic heart failure
• Treatment: Optimize blood pressure control, consider aldosterone antagonist if symptoms persist despite BP control (monitor potassium closely given eGFR 55) 5
• Prognosis: Symptoms should improve with BP optimization

2. Regional wall motion abnormalities or reduced ejection fraction:

• Proceed to stress testing (stress echocardiography preferred given ability to assess both ischemia and diastolic function) 1
• Consider coronary CT angiography if stress test is positive or equivocal
• Cardiac catheterization if high-risk features present

3. Significant valvular disease (especially aortic stenosis):

• Quantify severity
• Refer to cardiology for intervention consideration if severe

4. Normal echocardiogram:

• Reconsider pulmonary causes (CT chest without contrast to evaluate parenchymal disease)
• Consider cardiopulmonary exercise testing to differentiate cardiac vs. pulmonary vs. deconditioning 10

Common Pitfalls to Avoid

1. Do not assume pleuritic pain excludes cardiac disease—the exertional component is key
2. Do not reduce losartan dose based solely on eGFR 55; this level does not require adjustment 6, 7, 8
3. Do not add aldosterone antagonist (spironolactone/eplerenone) until after echocardiogram confirms heart failure, and only with careful potassium monitoring given eGFR 55 5
4. Do not order stress testing before echocardiography—echo provides essential structural information that guides all subsequent decisions 1, 2
5. Do not ignore the occasional palpitations—if echo shows structural disease, consider 30-day event monitor to exclude paroxysmal arrhythmias contributing to symptoms

Immediate Actions Summary

1. Order transthoracic echocardiogram (with Doppler for diastolic function assessment)
2. Add second antihypertensive (amlodipine 5 mg or chlorthalidone 12.5 mg)
3. Restart statin therapy (atorvastatin 40 mg or rosuvastatin 20 mg)
4. Check basic metabolic panel in 3-5 days after medication changes
5. Counsel patient to avoid NSAIDs and potassium-rich foods/supplements